GlassScriptPhysician profile
Irwin G Glassman
NPI 1568575801
$1,365.51
in general payments reported to CMS, 2019-2025
21 companies · $88.74 in 2025
The $88.74 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $241 · 2020: $27.92 · 2021: $124 · 2022: $266 · 2023: $284 · 2024: $334 · 2025: $88.74.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $707.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $706.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $280.02 | 2021-2023 | |
| Caldera Medical, INC | $162.16 | 2024 | Desara |
| Daiichi Sankyo INC. | $140.82 | 2019-2024 | Injectafer |
| Astellas Pharma US INC | $127.31 | 2023-2025 | Veozah |
| Mayne Pharma Commercial LLC | $90.04 | 2023-2025 | |
| Pfizer INC. | $83.40 | 2019-2023 | |
| Organon LLC | $71.40 | 2022-2024 | Nexplanon |
| Vertical Pharmaceuticals, LLC | $51.78 | 2019 | |
| Roche Diagnostics Corporation | $51.61 | 2019 | |
| Hologic Sales and Service, LLC | $45.23 | 2021 | |
| Scynexis, INC. | $37.90 | 2022 | |
| Therapeuticsmd, INC. | $36.40 | 2019-2021 | |
| Allergan, INC. | $30.34 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $29.10 | 2022-2023 | |
| Covidien LP | $26.83 | 2019-2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $22.68 | 2023 | Bulkamid, Axonics |
| Sage Therapeutics, LLC | $21.94 | 2024 | |
| Minerva Surgical, INC | $15.21 | 2025 | |
| Octapharma USA, INC. | $14.97 | 2025 | Fibryga |
| Sumitomo Pharma America, INC. | $14.15 | 2023 | Myfembree |
| Lupin INC. | $12.22 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Irwin Glassman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.